get a key
steadybase-$ company OVID
account_id none on file
legal_name Ovid Therapeutics Inc.
ticker OVID
cik 1636651
domain ovidrx.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 9 executives 4 family 0
why_nownone on file
callsnone on file
filings
Other general and administrative expenses include costs associated with operating as a public company, travel expenses, conferences, professional fees for auditing, tax and legal services, and facility-related costs.

filing / Aug 13, 2026 / receipt

The increase in general and administrative expenses is primarily due to increased accounting and audit, legal, business development and other professional fees, as well as an increase in payroll and related expenses resulting from increased headcount between the three month periods as well as recognition of approximately $0.3 million of severance costs and sign-on bonuses in the three months ended June 30, 2026.

filing / Aug 13, 2026 / receipt

We may be required to take additional actions beyond cost reduction measures initiated to address our liquidity needs, including exploring other strategic options, reduce operating expenses or delaying, reducing the scope of, discontinuing or altering our research and development activities.

filing / Aug 13, 2026 / receipt

In September 2021, the Company entered into a 10-year lease agreement for its corporate headquarters with a term commencing March 10, 2022, for approximately 19,000 square feet of office space at Hudson Commons in New York, New York.

filing / Aug 13, 2026 / receipt

Severance expense 209 - 209 435 Gain from recovery of fraudulent funds transfer - - - 1,800 Depreciation and amortization 16 99 51 240 26 Table of Contents Item 2.

filing / Aug 13, 2026 / receipt

Other general and administrative expenses include costs associated with operating as a public company, travel expenses, conferences, professional fees for auditing, tax and legal services, and facility-related costs.

filing / May 12, 2026 / receipt

resulting from lower headcount between the three month periods as well as recognition of approximately $0.6 million of severance costs and sign-on bonuses in the three months ended March 31, 2025.

filing / May 12, 2026 / receipt

In September 2021, the Company entered into a 10-year lease agreement for its corporate headquarters with a term commencing March 10, 2022, for approximately 19,000 square feet of office space at Hudson Commons in New York, New York.

filing / May 12, 2026 / receipt

Severance expense - 435 Gain from recovery of fraudulent funds transfer - 1,800 Depreciation and amortization 35 141 24 Table of Contents Item 2.

filing / May 12, 2026 / receipt

executives
Charles Carter Chief Financial Officer linkedin receipt
Jeffrey Rona Chief Business and Financial Officer linkedin receipt
Jeremy M. Levin President - receipt
Robert Michael Poole director - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2026-07-08 Chief Financial Officer, appointed sec_8k
2021-08-11 director, appointed sec_8k
2021-07-08 President, appointed sec_8k
2021-06-04 Chief Business and Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$